Who are we?

NeuroTidal Dx was founded in 2024 by scientists in the fields of protein chemistry and biomedical sciences. With our knowledge of protein chemistry of disease, we developed FibrilPaint, a specific binder of amyloid. Now, we are turning our invention into a biomarker assay. Our aim is to facilitate patient diagnosis, and provide a quantitative readout of disease stage.